EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic Value of Native T1 and T2 Mapping in Differentiating Clinically Suspected Amyloidosis and Hypertrophic Cardiomyopathy

Sena Unal iD, Caglar Uzun, Sena Bozer Uludag iD, Cuneyt Yamak iD, Turkan Seda Tan, Elif Peker iD

Diagnostics · 20.05.2026 · 16 (10) · 1558

DOI: 10.3390/diagnostics16101558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 20.05.2026. Verfasst von Sena Unal und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, School of Medicine, Ankara University, Hacettepe Mahallesi A. Adnan Saygun Cad. No: 35, 06230 Altındağ, Ankara, Türkiye. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Differentiating clinically suspected cardiac amyloidosis from hypertrophic cardiomyopathy (HCM) remains a significant clinical challenge, especially when contrast-enhanced imaging is contraindicated. This study evaluated the potential diagnostic utility of non-contrast cardiac MRI parameters, specifically native T1 and T2 mapping, as supportive indicators in this differential diagnosis.

Methods

This retrospective single-center study included 20 patients with clinically suspected amyloidosis (based on combined clinical and echocardiographic assessment), 20 patients with HCM, and 20 healthy controls. Cine imaging and native T1/T2 mapping were analyzed. Myocardial, blood-pool, and liver T1/T2 values, along with morphological parameters, were recorded. N-terminal pro–B-type natriuretic peptide (NT-proBNP) and troponin levels, when available, were documented retrospectively for descriptive purposes. Receiver operating characteristic (ROC) analyses were performed to assess the discriminatory performance of imaging parameters.

Results

Patients in the suspected amyloidosis group demonstrated significantly higher myocardial, blood-pool, and liver T1 values, as well as higher myocardial T2 values, compared with both the HCM and control groups (p < 0.001). Myocardial T1 showed strong discriminatory performance for differentiating suspected amyloidosis from controls (cut-off 1061 ms, AUC = 0.975). In distinguishing suspected amyloidosis from HCM, blood-pool T1 (AUC = 0.900) and myocardial T1 (AUC = 0.938) provided the highest diagnostic performance. Additionally, elevated NT-proBNP (>1000 pg/mL in 93% of tested cases) and troponin levels were observed in the suspected amyloidosis group, consistent with increased myocardial stress.

Conclusions

Native T1 and T2 mapping may offer valuable supportive information in differentiating clinically suspected amyloidosis from HCM on non-contrast MRI. Myocardial and blood-pool T1 values appear to provide complementary tissue characterization, which may be particularly useful when gadolinium administration or invasive procedures are not feasible. These findings suggest a role for non-contrast mapping in the diagnostic workup but require further validation in larger, biopsy-confirmed multicenter cohorts.

Schlagwörter

Stichwörter der Autor:innen

T1 mappingT2 mappingamyloidosiscardiac MRIhypertrophic cardiomyopathy

Autor:innen und Institutionen

  • Department of Radiology, School of Medicine, Ankara University, Hacettepe Mahallesi A. Adnan Saygun Cad. No: 35, 06230 Altındağ, Ankara, Türkiye.
  • Department of Radiology, Tosya State Hospital, A. Raşit Urkaya Sok., Dilküşah Mahallesi No: 2, 37300 Tosya, Kastamonu, Türkiye.
  • Department of Cardiology, School of Medicine, Ankara University, Hacettepe Mahallesi A. Adnan Saygun Cad. No: 35, 06230 Altındağ, Ankara, Türkiye.

ORCID-Profile: Sena Unal, Sena Bozer Uludag, Cuneyt Yamak, Elif Peker

Zitieren

APA

Unal, S., Uzun, C., Bozer Uludag, S., Yamak, C., Tan, T. S., & Peker, E. (2026). Diagnostic Value of Native T1 and T2 Mapping in Differentiating Clinically Suspected Amyloidosis and Hypertrophic Cardiomyopathy. Diagnostics, 16(10), 1558. https://doi.org/10.3390/diagnostics16101558

Vancouver

Unal S, Uzun C, Bozer Uludag S, Yamak C, Tan TS, Peker E. Diagnostic Value of Native T1 and T2 Mapping in Differentiating Clinically Suspected Amyloidosis and Hypertrophic Cardiomyopathy. Diagnostics. 2026;16(10):1558. doi:10.3390/diagnostics16101558

BibTeX
@article{Unal2026,
  author = {Unal, Sena and Uzun, Caglar and Bozer Uludag, Sena and Yamak, Cuneyt and Tan, Turkan Seda and Peker, Elif},
  title = {Diagnostic Value of Native T1 and T2 Mapping in Differentiating Clinically Suspected Amyloidosis and Hypertrophic Cardiomyopathy},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {10},
  pages = {1558},
  doi = {10.3390/diagnostics16101558}
}
Kostenlos starten →